Live Breaking News & Updates on Bath Ankylosing Spondylitis Activity Index

email article
Despite recent advances in the understanding of axial spondyloarthritis, long delays in diagnosis persist, leaving patients at risk for impaired quality of life and irreversible spinal damage, European researchers reported.
Among patients enrolled in the European Map of Axial Spondyloarthritis (EMAS) database, the average delay in diagnosis was 7.4 years, according to Marco Garrido-Cumbrera, PhD, of the University of Seville in Spain, and colleagues.
Many patients may undergo unnecessary and/or invasive testing and receive inadequate treatment for their condition, which may ultimately lead to poorer prognostic outcomes, the researchers wrote in the study online in
They explained that the insidious onset of axial spondyloarthritis, which includes both radiographic and nonradiographic forms of spinal inflammation, poses significant challenges in diagnosis, and patients typically see multiple healthcare providers before the diagnosis is made. Va ....

Marco Garrido Cumbrera , Novartis Pharma , University Of Seville , Axial Spondyloarthritis International Federation , European Map , Axial Spondyloarthritis , Bath Ankylosing Spondylitis Activity Index , நோவர்த்திச் பார்மா , பல்கலைக்கழகம் ஆஃப் செவில்லே , ஐரோப்பிய வரைபடம் , அச்சு ஸ்பொந்தய்லோஆறத்ரிடிச் ,